ADUS Addus HomeCare Corp
Services-Home Health Care Services · Nasdaq · SEC CIK 1468328 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY11.5%
TTM net income YoY29.7%
TTM EPS YoY29.0%
Revenue 3-yr CAGR13.4%
Net income 3-yr CAGR24.4%
Margins
Gross margin32.3%
Operating margin10.3%
Net margin7.4%
FCF margin9.6%
EBITDA margin11.4%
Returns
ROE10.0%
ROA7.7%
ROIC (approx.)10.5%
Asset turnover1.05x
Leverage & solvency
Liabilities / assets18.6%
Debt / equity0.02x
Current ratio1.64x
Interest coverage19.72x
Cash quality & payout
Operating cash flow / net income1.37x
Accruals ratio-2.9%
Payout ratio—
Capex / revenue0.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $1.42B | $1.15B |
| Cost of revenue | $960.66M | $779.58M |
| Gross profit | $461.87M | $375.02M |
| SG&A expense | $306.85M | $258.80M |
| Operating income | $138.62M | $102.69M |
| Interest expense | $13.61M | $7.73M |
| Pretax income | $127.44M | $99.35M |
| Income tax | $31.54M | $25.75M |
| Net income | $95.91M | $73.60M |
| EBITDA | $155.03M | $116.22M |
| EPS (basic) | 5.31 | 4.33 |
| EPS (diluted) | 5.22 | 4.23 |
| Weighted avg. shares (diluted) | 18.39M | 17.38M |
| Balance sheet | ||
| Cash & equivalents | $81.62M | $98.91M |
| Receivables | $151.69M | $122.88M |
| Current assets | $269.49M | $260.38M |
| PP&E, net | $25.00M | $24.70M |
| Goodwill | $996.70M | $970.56M |
| Intangibles | $102.41M | $109.64M |
| Total assets | $1.44B | $1.41B |
| Current liabilities | $149.49M | $155.87M |
| Long-term debt | $120.96M | $218.44M |
| Total debt | $120.96M | $218.44M |
| Total liabilities | $352.00M | $442.14M |
| Shareholders' equity | $1.09B | $970.49M |
| Net debt | $39.34M | $119.53M |
| Shares outstanding | 18.52M | 18.15M |
| Cash flow statement | ||
| Operating cash flow | $111.51M | $116.43M |
| Capital expenditure | $7.72M | $6.05M |
| Free cash flow | $103.79M | $110.38M |
| Investing cash flow | -$32.50M | -$354.61M |
| Financing cash flow | -$96.30M | $272.30M |
| Depreciation & amortization | $16.41M | $13.53M |
| Stock-based compensation | $16.42M | $11.16M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.